Median changes in lipid mediators in responders (green) and non-responders (red) by treatment group.
Top row: EPA-derived lipid mediators; middle row: DHA-derived lipid mediators; and bottom row: AA-derived lipid mediators. *Within the 4 g/d EPA arm, reductions in hs-CRP were significantly correlated with reductions in IDS-C30 scores (Spearman correlations among changes in variables from baseline to week 12 in the 4 g/d treatment group.*